Kyle Sable - 26 Feb 2026 Form 4 Insider Report for Perimeter Solutions, Inc. (PRM)

Signature
/s/ Noriko Yokozuka, as Attorney-in-Fact
Issuer symbol
PRM
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
02 Mar 2026, 17:29:25 UTC
Previous filing
16 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sable Kyle Chief Financial Officer C/O PERIMETER SOLUTIONS, INC., 8000 MARYLAND AVE., SUITE 350, CLAYTON /s/ Noriko Yokozuka, as Attorney-in-Fact 02 Mar 2026 0002001580

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRM Stock Option (right to buy) Award $0 +50,000 +100% $0.000000 100,000 26 Feb 2026 Common Stock 50,000 $13.24 Direct F1
transaction PRM Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 26 Feb 2026 Common Stock 20,000 $3.89 Direct F2
transaction PRM Stock Option (right to buy) Award $0 +100,000 +50% $0.000000 300,000 26 Feb 2026 Common Stock 100,000 $8.36 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 27, 2024, the reporting person was granted an option to purchase 250,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 50,000 shares of common stock.
F2 On November 16, 2023, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 20,000 shares of common stock.
F3 On May 6, 2022, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 100,000 shares of common stock.